Kimball Electronics’ first quarter results for 2026 were met with a negative market reaction, as revenue declined compared to the same period last year and missed analysts’ expectations. Management pointed to the continued strength of the Medical segment, which delivered sequential growth and helped offset softness in Automotive and Industrial markets. CEO Ric Phillips noted, “Sales increased sequentially compared to Q2 driven by strong growth in our Medical vertical market,” underscoring the importance of this business in stabilizing results amid broader end-market challenges.
Is now the time to buy KE? Find out in our full research report (it’s free for active Edge members).
Kimball Electronics (KE) Q1 CY2026 Highlights:
- Revenue: $352.9 million vs analyst estimates of $356.3 million (5.8% year-on-year decline, 0.9% miss)
- Adjusted EPS: $0.33 vs analyst estimates of $0.34 (in line)
- Adjusted EBITDA: $22.83 million vs analyst estimates of $22.97 million (6.5% margin, 0.6% miss)
- The company reconfirmed its revenue guidance for the full year of $1.43 billion at the midpoint
- Operating Margin: 3.6%, in line with the same quarter last year
- Market Capitalization: $620.7 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Kimball Electronics’s Q1 Earnings Call
- Michael Crawford (B. Riley Securities) asked how the ramp of the Indianapolis facility will affect margins and revenue. CEO Ric Phillips explained production will start by year-end and margin benefit depends on the pace of program onboarding.
- Derek Soderberg (Cantor Fitzgerald) questioned how much capacity at the new facility is already booked. Phillips responded that it is still early, but customer interest is high and there is room for expansion as demand grows.
- Soderberg also asked about pricing competitiveness in the Medical segment. CFO Jana Croom described pricing as aggressive but rational, driven by the need for robust supply chains and continued demand growth.
- Soderberg inquired about the likelihood of larger M&A deals given the company’s improving balance sheet. Phillips confirmed M&A is a priority, with a focus on adding capabilities, customers, and geographic reach.
- Maxwell Michaelis (Lake Street Capital Markets) sought clarity on the target for new Medical customers and the impact of new applications. Croom confirmed they are on track for their goal and that both new and existing technologies are being deployed for new customers.
Catalysts in Upcoming Quarters
In the coming quarters, our analysts will be watching (1) the rate at which Medical programs ramp in the new Indianapolis facility and translate into higher utilization and margins; (2) whether Automotive demand stabilizes or improves amid macroeconomic and regulatory shifts, particularly for EV components; and (3) progress on M&A activity, especially in Medical, as well as the addition of new customers. Developments in Industrial end-markets and geopolitical risks will also be closely monitored.
Kimball Electronics currently trades at $25.82, down from $27.15 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
The Best Stocks for High-Quality Investors
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
